Gilead Sciences Inc. (GILD)

NASDAQ: GILD · Real-Time Price · USD

104.04

-2.50 (-2.35%)

At close: May 01, 2025, 1:51 PM

Gilead Sciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	28.75B	27.12B	27.28B	27.3B	24.69B	22.45B	22.13B	26.11B	30.39B
Cost of Revenue	6.25B	6.5B	5.66B	6.6B	4.57B	4.67B	4.85B	4.37B	4.26B
Gross Profit	22.5B	20.62B	21.62B	20.7B	20.12B	17.77B	17.27B	21.74B	26.13B
Operating Income	1.66B	7.61B	7.33B	7.41B	7.03B	4.29B	8.2B	14.12B	17.63B
Interest Income	281M	n/a	935M	1B	984M	995M	n/a	n/a	n/a
Pretax Income	690M	6.86B	5.81B	8.28B	1.67B	5.16B	7.8B	13.53B	17.1B
Net Income	480M	5.67B	4.59B	6.22B	89M	5.39B	5.46B	4.63B	13.5B
Selling & General & Admin	6.09B	6.09B	5.67B	5.25B	5.15B	4.38B	4.06B	3.88B	3.4B
Research & Development	5.91B	6.92B	4.98B	5.36B	5.04B	9.11B	5.02B	3.73B	5.1B
Other Expenses	8.84B	n/a	-581M	-639M	-1.42B	1.87B	676M	523M	428M
Operating Expenses	20.84B	13.67B	10.65B	10.61B	10.19B	13.49B	9.07B	7.61B	8.5B
Interest Expense	977M	944M	935M	1B	984M	995M	1.08B	1.12B	964M
Selling & Marketing Expenses	n/a	826M	778M	735M	795M	784M	587M	600M	618M
Cost & Expenses	27.09B	19.69B	16.31B	17.21B	14.76B	18.16B	13.93B	11.98B	12.76B
Income Tax Expense	211M	1.25B	1.25B	2.08B	1.58B	-204M	2.34B	8.88B	3.61B
Shares Outstanding (Basic)	1.25B	1.25B	1.25B	1.26B	1.26B	1.27B	1.3B	1.31B	1.34B
Shares Outstanding (Diluted)	1.25B	1.26B	1.26B	1.26B	1.26B	1.28B	1.31B	1.32B	1.36B
EPS (Basic)	0.38	4.54	3.66	4.96	0.07	4.24	4.20	3.54	10.08
EPS (Diluted)	0.38	4.50	3.64	4.93	0.07	4.22	4.17	3.51	9.94
EBITDA	1.66B	10.5B	8.85B	11.33B	4.13B	7.56B	10.3B	15.93B	19.22B
EBIT	1.67B	7.8B	6.75B	9.28B	2.65B	6.16B	8.88B	14.65B	18.06B
Depreciation & Amortization	-5M	2.69B	2.1B	2.05B	1.48B	1.4B	1.43B	1.29B	1.16B